Two antihypertensives, alphasartan and betasartan, are being compared in a randomised crossover trial for their effect on reducing systolic and diastolic blood pressure in participants with known Stage 1 or 2 hypertension. | Medibuddy
13th February 2024

Two antihypertensives, alphasartan and betasartan, are being compared in a randomised crossover trial for their effect on reducing systolic and diastolic blood pressure in participants with known Stage 1 or 2 hypertension.

Two antihypertensives, alphasartan and betasartan, are being compared in a randomised crossover trial for their effect on reducing systolic and diastolic blood pressure in participants with known Stage 1 or 2 hypertension. 

Which of the following is FALSE regarding a crossover trial?

Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.